Chiricozzi, A., Di Nardo, L., Talamonti, M., Galluzzo, M., De Simone, C., Fabbrocini, G., et al. (2022). Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy. DERMATITIS, 33(3), 25-29 [10.1097/DER.0000000000000814].

Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy

Bongiorno, Maria Rita;
2022-01-01

2022
Chiricozzi, A., Di Nardo, L., Talamonti, M., Galluzzo, M., De Simone, C., Fabbrocini, G., et al. (2022). Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy. DERMATITIS, 33(3), 25-29 [10.1097/DER.0000000000000814].
File in questo prodotto:
File Dimensione Formato  
Patients Withdrawing Dupilumab Monotherapy for.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 147.04 kB
Formato Adobe PDF
147.04 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/582525
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact